Related Experiment Video
Updated: May 14, 2026

Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice
Published on: May 16, 2021
Impaired Akt phosphorylation in insulin-resistant human muscle is accompanied by selective and heterogeneous
1Diabetes and Obesity Research Program, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, 2010 NSW, Australia.
Aims/Hypothesis:
Muscle insulin resistance, one of the earliest defects associated with type 2 diabetes, involves changes in the phosphoinositide 3-kinase/Akt network. The relative contribution of obesity vs insulin resistance to perturbations in this pathway is poorly understood.
Methods:
We used phosphospecific antibodies against targets in the Akt signalling network to study insulin action in muscle from lean, overweight/obese and type 2 diabetic individuals before and during a hyperinsulinaemic-euglycaemic clamp.
Results:
Insulin-stimulated Akt phosphorylation at Thr309 and Ser474 was highly correlated with whole-body insulin sensitivity. In contrast, impaired phosphorylation of Akt substrate of 160 kDa (AS160; also known as TBC1D4) was associated with adiposity, but not insulin sensitivity. Neither insulin sensitivity nor obesity was associated with defective insulin-dependent phosphorylation of forkhead box O (FOXO) transcription factor. In view of the resultant basal hyperinsulinaemia, we predicted that this selective response within the Akt pathway might lead to hyperactivation of those processes that were spared. Indeed, the expression of genes targeted by FOXO was downregulated in insulin-resistant individuals.
Conclusions/Interpretation:
These results highlight non-linearity in Akt signalling and suggest that: (1) the pathway from Akt to glucose transport is complex; and (2) pathways, particularly FOXO, that are not insulin-resistant, are likely to be hyperactivated in response to hyperinsulinaemia. This facet of Akt signalling may contribute to multiple features of the metabolic syndrome.
Insights
Muscle insulin resistance in type 2 diabetes involves the Akt pathway. Obesity, not insulin resistance, impairs AS160 phosphorylation, while FOXO gene expression is downregulated, suggesting pathway hyperactivation.
Area of Science:
- Endocrinology
- Molecular Biology
- Metabolic Syndrome Research
Background:
- Muscle insulin resistance is an early defect in type 2 diabetes, linked to the phosphoinositide 3-kinase/Akt signaling network.
- The distinct roles of obesity and insulin resistance in disrupting this pathway remain unclear.
Purpose of the Study:
- To investigate the differential effects of obesity and insulin resistance on the Akt signaling pathway in muscle.
- To understand the relationship between insulin sensitivity, adiposity, and specific Akt pathway components.
Main Methods:
- Utilized phosphospecific antibodies to examine Akt signaling in muscle tissue from lean, overweight/obese, and type 2 diabetic individuals.
- Employed a hyperinsulinemic-euglycemic clamp to assess insulin action before and during the clamp.
Main Results:
- Insulin-stimulated Akt phosphorylation (Thr309, Ser474) strongly correlated with whole-body insulin sensitivity.
- Impaired phosphorylation of Akt substrate of 160 kDa (AS160) was linked to adiposity, independent of insulin sensitivity.
- Insulin sensitivity and obesity did not correlate with defects in insulin-dependent forkhead box O (FOXO) phosphorylation.
- Downregulation of FOXO-targeted genes was observed in insulin-resistant individuals, despite normal FOXO phosphorylation.
Conclusions:
- Akt signaling exhibits non-linearity, with distinct responses to insulin and obesity.
- The pathway from Akt to glucose transport is complex and not fully elucidated.
- Insulin-spared pathways like FOXO may become hyperactivated due to basal hyperinsulinemia in insulin resistance.
- This hyperactivation of specific Akt pathway components could contribute to metabolic syndrome features.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Insulin: The Receptor and Signaling Pathways
cAMP-dependent Protein Kinase Pathways
Type II Diabetes II: Pathophysiology
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
